CD44 and embryonal carcinoma: To address this issue, we performed studies on the established human ovarian cancer cell line A2780 and the embryonal carcinoma cell line NTera2 and evaluated the potential stemness of cells sorted according to expression of the cell-surface stem cell markers CD24 plus CD44 and CD133 plus SSEA4, respectively [24, 25].